Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Fortress Biotech (FBIO) EBIT Margin: 2013-2025

Historic EBIT Margin for Fortress Biotech (FBIO) over the last 13 years, with Sep 2025 value amounting to -38.63%.

  • Fortress Biotech's EBIT Margin rose 11240.00% to -38.63% in Q3 2025 from the same period last year, while for Sep 2025 it was -143.55%, marking a year-over-year increase of 2615.00%. This contributed to the annual value of -191.38% for FY2024, which is 2295.00% down from last year.
  • According to the latest figures from Q3 2025, Fortress Biotech's EBIT Margin is -38.63%, which was up 82.62% from -222.22% recorded in Q2 2025.
  • Fortress Biotech's EBIT Margin's 5-year high stood at -38.63% during Q3 2025, with a 5-year trough of -473.63% in Q1 2023.
  • Moreover, its 3-year median value for EBIT Margin was -169.85% (2025), whereas its average is -191.48%.
  • Examining YoY changes over the last 5 years, Fortress Biotech's EBIT Margin showed a top increase of 26,737bps in 2023 and a maximum decrease of 27,605bps in 2023.
  • Over the past 5 years, Fortress Biotech's EBIT Margin (Quarterly) stood at -339.25% in 2021, then skyrocketed by 620bps to -333.05% in 2022, then spiked by 23,472bps to -98.34% in 2023, then slumped by 5,930bps to -157.64% in 2024, then soared by 11,240bps to -38.63% in 2025.
  • Its last three reported values are -38.63% in Q3 2025, -222.22% for Q2 2025, and -169.85% during Q1 2025.